HFEA allows PGD and tissue typing
The UK's Human Fertilisation and Embryology Authority (HFEA) announced last week that it would, in principle, allow the use of HLA (Human Leukocyte Antigen) typing, more commonly known as 'tissue typing', in conjunction with preimplantation genetic diagnosis (PGD) for serious disease. The HFEA will consider each application to use the...
Comment
Is a tissue-matched child a commodity?
by Juliet Tizzard
This week's BioNews reports on the HFEA's announcement that it will in principle permit preimplantation genetic diagnosis (PGD) and tissue typing in IVF units in the United Kingdom. But whilst families keenly awaiting this opportunity were delighted, not everyone was happy to hear the news. There was, of course, the...